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Abstract
Background and Objective: Light and lasers in medical therapy have made dramatic strides since their invention five
decades ago. However, the manufacture of lasers can be complex and expensive which often makes treatments limited and
costly. Further, no single laser will provide the correct parameters to treat all things. Hence, laser specialists often need
multiple devices to practice their specialty. A new concept is described herein that has the potential to replace many lasers
and light sources with a single ‘tunable’ device.
Study Design/Material and Methods: This device amplifies spontaneous emission of radiation by capturing and retaining
photons through total internal reflection, hence the acronym Total Reflection Amplification of Spontaneous Emission of
Radiation, or TRASER.
Results: Specific peaks of light can be produced in a reproducible manner with high peak powers of variable pulse
durations, a large spot size, and high repetition rate.
Conclusion: Considering the characteristics and parameters of Traser technology, it is possible that this one device would
likely be able to replace the pulsed dye laser and many other light based systems.
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Introduction
This paper will introduce a new concept in light amplification
and delivery for medical, domestic, and industrial uses. It will also
define peak wavelengths, pulse-widths, pulse modes and fluence
levels of spontaneous emission from multiple dyes. Trasers can be
defined according to their excited media, and are known as pulsed
dye Trasers or crystal Trasers, the latter for the solid crystal dye
media grown specifically for this device.
For decades, laser and light sources have provided tremendously
important benefits to industry, medicine and mankind. Since
Anderson and Parrish developed the concept of selective
photothermolysis, laser surgeons have been able to match the
wavelength and pulse-width to an anatomical structure, and to
selectively heat this without collateral damage [1]. The ability to
amplify light by stimulated emission of radiation is the cornerstone
of laser technology; it is this amplification (along with collimation,
monochromicity, and in-phase characteristics) that differentiates it
from other light sources.
The development of the Traser represents a novel and efficient
method to induce, capture and amplify light, and to do so with a
tunable range of wavelengths. A Traser is not a laser; it is
fundamentally different, and, in many ways, much simpler in
design. A Traser utilizes the energy from, for example, a flashlamp
to induce the spontaneous emission of photons from a fluorescent
dye in solution, or ions impregnated in a crystal structure. The
narrow band of fluorescence has a peak of intensity that depends
on the Stokes shift characteristics of selected fluorescent media
within the arc lamp configuration [2] The light generated can be
tuned from UVA to near infrared (NIR). As opposed to a laser, a
Traser has no optical resonator, no output coupler, and no
stimulated emission in the classical sense. Unlike a laser, a Traser
induces light that is non-coherent and non-collimated. And in
contrast to the intense pulsed light (IPL), none of the emitted
photons are derived from the flashlamp, there are no filters, and
no filter technology (Figs. 1a, 1b). Amplification of light is achieved
by capturing and trapping 46–61% of spontaneously induced
photons within a liquid jet or solid body of a high refractive index
and the option for special coating so as enhance total internal
reflection (TIR).
Traser technology is simple in design and generally more
ecofriendly than some of the devices that it could possibly replace.
In this regard, Traser technology does not preclude the use of
flammable and toxic solvents or toxic additives, but to date Trasers
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35899have been operated with water and no additives at all. Many of the
fluorescent dyes chosen thus far are non-toxic and, in any event,
the user never comes into contact with these dyes. All currently
selected dyes are water soluble, and do not require hazardous
solvents or additives. When required, they are reclaimed by a filter
loop, which in less than a minute can completely eliminate the dye
and purify the circulating water. This water is not only
reconstituted with new dyes within the Traser circulation cavity,
but is also used to cool the device. Consumables would likely be
minimal with the life of the flashlamp and dye being years,
depending on utilization. Hence, the cost of operation of a Traser
should be modest, both for medical facilities and for patients. The
likely versatility of this technology – being able to produce UVA,
blue, green, orange, red, and NIR – will mean that one Traser
inducing an array of tunable wavelengths might replace a number
of separate devices currently required for clinical practice.
Materials and Methods
Three highly fluorescent Traser dyes (pyrromethene 556,
rhodamine 590, and sulforhodamine 640 chloride (Exciton, Inc.
Dayton, Ohio)) were tested in a standardized arrangement.
For optimum power, each of these dyes was dissolved, one at the
time, at a specific concentration in distilled water and recirculated
through a cylindrical dye cell comprising 5/7684 mm N-LASF43
glass (Schott, GmbH, Mainz, Germany). The dye cell was
irradiated with light from two xenon flashlamps (Applied Photon
Technology, Inc. Hayward, CA) of 5/6.2680 mm and with a fill
pressure of 1400 Torr. The lamps were dressed with cooling water
flow jackets of cerium doped glass (Haereus Quarzglas GmbH &
Co. KG, Kleinostheim, Germany). The lamp and flow-jacket
assemblies and the dye cell were enclosed in a race track shaped
close-coupling reflector of unprotected silver sheet (SurePure, Inc.
Florham Park, NJ), the latter providing a modest 80% specular
reflectivity at 534 nm. A silver mirror (ThorLabs, Inc. Newton,
NJ, P/N PF03-03-P01) was located 0.5 mm from the proximal
end of the dye-cell, the gap being occupied by the dye solution
flow chamber. The light was passively coupled into a non-oriented
sapphire crystal waveguide, with a diameter of 8 mm (0.5 cm
2
cross section) and length of 85 mm. The barrel of the sapphire
waveguide was industrial polished and coated with Polytetraflu-
oroethylene (PTFE). The fluorescent dye solvent was cooled to 1–
3uC using a 700 W inert Peltier cooler (Rockport Consulting
Services, Inc. Newport Beach, CA). An inert 2 mm particle filter
(McMASTER-CARR, Inc. Princeton, NJ) was utilized in the dye
circulation loop, and circulated at a speed of 2.5 L/min. The
cooled dye solution provided initial refrigeration for the sapphire
waveguide before excitation, with the contact sapphire treatment
tip being at about 1–3uC.
The electronic capacitor bank of 36,600 mF was set at 640
VDC, and each lamp was discharged by separate insulated gate
bipolar transistor (IGBT) switches. The lamps were simmered at
40 V and 600 mAmp. The lamps were pulsed simultaneously as
single pulses up to 2 ms, or in a train formation for longer
timeframes with individual pulses of 1 ms duration at a duty cycle
of 50% for up to 80 ms. In a few cases, trains comprised pulses of
up to 1.5 ms (Table 1). Lamp envelope deterioration was noted at
one occasion with pulse train durations longer than 80 ms in
response to high wall loading. Rather than complicating the
comparison of data by decreasing the capacitor bank voltage or
altering the duty cycle, no pulses exceeding 80 ms were tested in
this study.
The output was measured using a spectrum analyzer (Ocean
Optics, Inc., HR4000CG-UV-NIR, Dunedin, Fl), a Pyro-Stack
energy meter (Ophir, Ltd., Har Hotzvim, Israel, model
L40150ADB-NS, P/N174241A with readout P/N 1Z02512). A
photodiode (CVI Melles Griot Laser Group, P/N 13DAS005,
Carlsbad, CA) was used to verify the pulsewidth. The laser dyes
where evaluated with respect to liquid concentration, light
spectrum and light fluence.
Results
Concentrations from 9.38610
24 g/L to 3000610
24 g/L were
evaluated and will be reported separately. Optimal concentrations
were established for each dye in relation to power and dye-cell
aspect ratios. These ranged from 0.0375 g/L for rhodamine 590
to 0.15 g/L for pyrromethene 556. Wavelength peaks ranged from
533 nm for pyrromethene 556 @ 0.0375 g/L to 662 nm for
sulforhodamine 640 chloride @ 0.15 g/L. The optimum power
yielding dye concentrations for the three dyes, subject to the dye
cell aspect ratio, are found in Table 1 and Figures 2–4. No
difference in emission peaks were found with increasing fluence or
increasing pulsewidth.
Fluences were assessed for all three dyes, and tested in single
pulse mode from 0.5–2.0 ms, and in pulse-train mode from 3–
79 ms. It should be noted that fluences were achieved well above
those normally recommended for clinical use. In the clinical
situation, this would be easily moderated by lowering the voltage
over the capacitor bank, reducing the duty cycle, or increasing the
treatment spot size, with one or all three resulting in lower
fluences. For the purposes of this study, diminishing these high
fluences by any of the said three options would have made a direct
comparison of the dyes impossible at many pulse widths. Table 1
lists the dyes in parallel mode for each dye, and with increasing
fluences. For all three dyes and with all pulse trains, the lamp duty
cycle is expressed as ‘on’ and ‘off’ times during the pulse-train. The
Figure 1. The Traser contains an internally reflecting body
hosting a fluorescent substance, ‘‘dye cell’’ (center); flash
lamps (above and below); a rear mirror (end left); an optional
output waveguide (right); an optional reflector cavity housing
the light source and the internally reflecting body (not shown).
Photons from the flashlamps excite the fluorescent material within the
dye cells, which spontaneously emit a different narrow spectrum of
light. Typically, the dye cell traps 45–62% of the spontaneous emission
by internal reflection. The internally reflected photons propagate axially
along the length of the dye cell or crystal in both directions. At the
proximal end of th e cell is placed a mirror, redirecting the light forward.
The light is passively coupled out at the distal end of the cell. A wave
guide is used to target the treatment area.
doi:10.1371/journal.pone.0035899.g001
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off.
Figs. 2–4 show Traser emission spectra from dyes exhibiting
lower to higher fluences, in the same order as in Table 1, including
their optimal dye concentrations, given the currently configured
dye cell aspect ratio.
It was important for us to demonstrate that the typical flashlamp
emission spectrum (Fig. 5) did not significantly contaminate the
spontaneous emission from the dye cell. On occasions, the
Table 1. Comparison of the average fluences in parallel mode of 3 sets of optimized dyes.
Spot Size; 8 mm diameter PM 556 Rh 590 S.Rh 640 Cl.
0.15 g/L 0.0375 g/L 0.075 g/L






















ms Ms ms J/cm2 J/cm2 J/cm2
0.5 1 0.5 – 6.9 5.5 4.04
1 1 1 – 12.2 9.7 7.39
2 1 2 – 18.3 16.0 12.39
3 2 1 1 16.5 15.0 11.66
4 2 1.5 1 26.9 21.2 19.08
9 5 1 1 45.2 41.1 32.06
19 10 1 1 81.5 78.8 59.56
39 20 1 1 132.5 128.2 99.81
59 30 1 1 165.8 159.8 127.68
79 40 1 1 187.1 179.8 139.52
PM 556=pyrromethene 556; Rh 590=rhodamine 590; S.Rh 640=sulforhodamine 640 chloride.
doi:10.1371/journal.pone.0035899.t001
Figure 2. Pyrromethene 556, 0.15 g/L. Peak at 544 nm.
doi:10.1371/journal.pone.0035899.g002
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graphs between 800 and 950 nm, some of which was contami-
nation from minor lamp light leakage into the laboratory, and
some of which was refracted at the interface between the water-
dye solution and the sapphire rod (Figs. 4,5). Pyrromethene 556 at
0.15 g/L had the highest fluence of the candidate dyes, at which
peaks all flashlamp leakage was completely suppressed.
As an example of the therapeutic potential for these dyes, the
pyrromethene 556 emission spectrum could be nicely superim-
posed over the absorption spectrum of oxygenated blood (Fig. 6).
Figure 3. Rhodamine 590, 0.0375 g/L. Peak 592 nm.
doi:10.1371/journal.pone.0035899.g003
Figure 4. Sulphorhodamine 640, 0.75 g/L. Peak at 658 nm.
doi:10.1371/journal.pone.0035899.g004
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to be strategically positioned at 662 nm at the area of greatest
discrepancy of absorption between hemoglobin and melanin,
clearly indicating hair as a candidate target.
There was no degradation of dyes over the duration of the
study. However, over an extended period one could expect
degradation, and these data will be presented in a separate paper.
Discussion
The heart of a Traser is by design simpler than a laser, has fewer
components such as an optical resonator or output coupler, and no
filters or frequency doubling crystals. It needs no mirror alignment
and has no lasing thresholds or population inversions to consider.
The output fluence is perfectly linear with the current going
through the lamp, and hence the power can be set by a CPU
calibration table for the voltage over the capacitor bank. By and
large, simpler engineering designs are associated with increased
reliability. The few consumables are inexpensive, generally non-
toxic, and extremely durable. The amplification process is not one
of stimulated emission of radiation. Rather it is based on the
trapping of 46–61% of the photons over a predetermined length of
a highly reflecting dye cell or solid host. In contrast, the surface of
a laser rod is typically non-reflecting in order to prevent parasitic
photon angles. Indeed, photons in a laser that propagate at angles
other than substantially parallel to the axis of the dye cell or crystal
will induce stimulated emission from excited matter in directions
that will not benefit the multiplicative build up of collimated
photons. In practice, they will decrease the amount of excited
molecules or ions available for lasing. As such these photons are
called ‘parasitic’, and their angles ‘parasitic angles’. In a crystal
laser it is common practice to not polish the barrel of the rod in
order to prevent total internal reflection, which would only
increase the amount of parasitic photons at parasitic angles.
Spontaneously emitted photons are arrayed in a non-collimated
spherical design. Of these, 46–61% are unable to escape the dye
cell because of TIR at the surface of the dye-cell or rod. In
addition, the dye cell or crystal rod can be designed with
appropriate low pass coatings to further improve refraction, and
almost completely prevent loss of spontaneous emission.
The specific peak of wavelength output can be varied by
altering the concentration of a particular dye, or by utilizing a
different fluorescent dye. To remove the existing dye, the solution
is passed through a deionizing filter, after which the purified
solvent, generally water, is reconstituted with a new dye pellet.
This process makes dye changes efficient and integrative, since the
circulating dye is also used as a cooling medium for the waveguide.
The key to understanding how to optimize the wavelength output
is by recognizing that, in response to a flashlamp pulse, fluorescent
dyes have a characteristic absorption pattern, and an equally
characteristic spontaneous output fluorescence (Stokes shift), which
peaks at a specific wavelength, based in part on red shift with
increasing dye concentrations.
Design of the dye cell determines the total energy output from
the device. A 5 mm diameter dye cell may generate the same
fluence as a 12 mm diameter dye cell, but the total energy
produced with the 12 mm diameter cell will be significantly
higher. This will have implications for device engineers, as there is
a maximal optimal diameter of the dye cell after which the fluence
will start to decrease with any further increase in diameter. This is
expressed as the relationship between the diameter and the length
of the dye cell, the so-called ‘aspect ratio’. In general, a larger
diameter dye cell will allow a larger treatment spot size, while
maintaining fluence. Decisions with regard to intended use
Figure 5. Flashlamp spectrum alone, without dye cell emission.
doi:10.1371/journal.pone.0035899.g005
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concentration.
There is some confusion about the concept of ‘amplification’.
The laws of nature require that, in both cases, laser and Traser,
there is no true ‘amplification’ of light energy. On the contrary,
there is a weakening of photonic energy during these processes,
wherein light is merely ‘concentrated’ over a predetermined area.
A Traser amplifies light no more and no less than a laser. In both
cases, for every one photon ‘out’ (with the energy E), there has
been one photon ‘in’ (with energy . E) from the so-called pump
source, for instance a flash-lamp. This is also the reason why
photons exiting a Traser or a laser have longer wavelength than
those entering the fluorescent media in these devices.
In the case of a crystal laser or a dye-laser there is.
1) a first photon, derived from a flash-lamp, (Lamp Derived
Photon 1 - LDP1) excites a fluorescent molecule (FM1), that
spontaneously emits a fluorescence derived photon (FDP1)
and
2) a second flash-lamp derived photon (LDP2) excites a different
fluorescent molecule (FM2) which will produce its own
photon FDP2. However, while FM2 is still in its excited state,
an FDP1 hits it and as a result two photons, FDP1’s identical
successor, namely FDP3, and FDP2 are launched at the same
moment. That is what is referred to as stimulated emission.
The fact that both photons are unidirectional (collimated) is
the critical mechanism by which laser light is concentrated
over a predetermined area. While this has significant benefits
in terms of delivery mechanisms, collimation is not
amplification. It is simply confinement of photons over a
smaller area than otherwise would have been the case, that is,
‘concentration of light’ rather than ‘amplification of light’.
Population inversion is a feature of distinction between a laser
and a Traser. Mirrors at both ends of a laser cavity augment
coherence of the unidirectional FDP1&3 photons in bi-axial
directions. With FDP3 and FDP2 photons oscillating between said
mirrors, more and more FDP3 and FDP2 are emitted in the same
bidirectional axis.
Based on the one photon ‘in’, and one photon ‘out’ concept,
what is achieved is a concentration of photons with a certain
directional properties. While this might be an oversimplification,
lasers do not amplify photonic energy or ever create more
photonic energy ‘out’ than was ever pumped ‘in’. On the contrary
there is a net loss in energy, photon for photon, of every photon
incident to and absorbed by the fluorescent and lasing medium to
every photon emitted by a laser as collimated light. In addition to a
decrease in photonic energy, there is a loss of fluorescent light
emitted in every other but axial directions from the fluorescent
medium, and of all the light from the so called pump-source not
absorbed and re-emitted by the lasing medium. The electro-
optical efficacy of a laser is typically about or less than 1–1.2%.
In the case of a crystal Traser or a dye Traser, the same process
described above induces both FDP1 and FDP2 photons, which are
confined in and travel through the same predetermined longitu-
dinal volume as do FDP1, FDP2 and FDP3 photons in a flash-
lamp ‘‘pumped’’ dye or crystal laser. However they do so at a
plurality of angles and are not coherent as in a laser. The
mechanism for concentrating light over a predetermined area in a
Traser is not based on stimulated emission, but instead on the
delta in refractive index of the fluorescent medium’s host and the
cladding of it, that is, air. Typically, 46–61%, of all FDP1 and
FDP2 photons are salvaged within the dye cell and concentrated
over a predetermined area. Note that FDP1 need not transcend
into FDP3 for this concentration of energy. In reality, it is almost
exclusively FDP1 and FDP2 that are being concentrated over this
area.
Although not entirely accurate, when we refer to spatial
concentration of photons as ‘amplification’, it serves the purpose
of differentiating both the Traser and the laser from other ways of
achieving spatial concentration of light, for instance with the use of
a focusing lens.
To summarize, the term ‘amplification’ of light has become
standard usage among laser engineers and would probably be
better understood as ‘concentration’ of light confined over a small
area. (The word LCSER doesn’t roll off the tongue quite so easily
as LASER, so we assume that ‘amplification’ is going to remain
the term du jour). If some are concerned about the use of the term
‘amplification’ in a Traser, then they might have the exact same
concern about the use of this word with regard a laser. If a laser
amplifies light, then a Traser, using the same principles of
quantum mechanics, also amplifies light. While we understand the
confusion, it’s a case of semantics.
Given the design of a Traser, it is generally more ecofriendly
and safer than corresponding dye lasers. For eco-friendliness we
are looking at four components, namely dye, solvent, additive and
material handling. The current dye lasers use flammable and toxic
organic solvents with additives such as the cyclooctatetraene
(COT). By comparison, the Trasers are operated using water as
the host (i.e. the solvent) for the Traser dye, and do not require
toxic solvent additives. Furthermore, the closed system in a Traser
avoids any dye or solvent contact with the operator. A Traser can
Figure 6. Light absorption by tissue chromophores [1].
doi:10.1371/journal.pone.0035899.g006
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without the use of any toxic solvents, solvent additives, or toxic
dyes. Even with the use of rhodamines, with water as a solvent and
without any additives, the Traser is ecofriendlier than the
corresponding lasers.
To understand the reasons why additives such as COT are
required in a dye laser, and not in a dye Traser, we offer the
following explanation. In a dye laser system, over time, an
increasing portion of the dye molecules, upon excitation, get
‘stuck’ in a non-fluorescing spinning and vibrational state, the so
called ‘triplet state’. While in this triplet state, the dye molecules
will not support either spontaneous or stimulated emission. To
counteract this problem in a dye laser, the population of triplet
state dye molecules is commonly reduced by the addition of agents
such as COT. This is a potentially irritating agent to the skin, eyes
and lungs, is flammable and ‘‘readily forms explosive mixtures
with air’’ [4].
Laser engineers tend not to use cladding around the fluorescent
media, which consequently results in leakage of light out of the
sides of the crystal rod or dye cell. This loss of photonic energy is
compensated, to some degree, with a leaking front mirror, a so-
called ‘‘output coupler’’. The overall electro-optical efficacy of a
dye laser is typically up to about 1.2% versus typically 2.5% for the
Trasers built to date.
The pulsed mechanism in this device can produce individual
pulses from 0.15–100 msec, only limited by the plasma growth
within the Xenon gas of the lamp, the size of the capacitor bank,
and the Traser software.
The Traser emission spectra match hemoglobin’s absorption
wavelengths, indicating that a Traser could indeed be harnessed to
treat the same vascular conditions as the PDLs by the same
selective photothermolysis mechanisms. For superficial port wine
stains, the shorter wavelengths with shorter pulse durations may be
optimal, and for those with thicker, more nodular problems, the
longer wavelengths with longer pulses might be preferred. Further,
one can predict good responses in patients with lentigenes and in
hair removal.
The current design of a Traser will allow physicians and laser
engineers the ability to produce highly variable parameters of
wavelength, pulse duration, fluence and spot size. For instance, the
current trend by the leading manufacturers of pulsed dye lasers is
to deliver individual pulses comprising 6 or 8 micropulses. If a
clinician deems this of use, a Traser device could deliver an
appropriate peak of energy with the same micropulsing technol-
ogy. However, some might consider that these high peak power
micropulses tend to induce partial vessel disruption, with or
without associated purpura [5]. Unless the vessel is totally
‘cooked’, revascularization from residual endothelium might be
responsible for recurrence. Further, locally induced angiogenic
growth factors may be responsible for the rapid rate of
revascularization. Given all this, the treating physician using a
pulsed dye Traser could choose true continuous pulses, tunable in
wavelength, and in 0.2 msec steps from 0.2–100 msec.
One example of a prime target for a Traser would be hair
removal. One could, for instance, resurrect the concept of using
light in the upper 600 s nm region. The early publications
concerning hair removal utilized ruby lasers (694 nm), and the
results were impressive [6]. That they went out of style was
unrelated to their efficacy, but rather their burdensome mainte-
nance, unreliability and temperamental behavior, and a maximal
pulse being limited to 3–4 msec. Our studies indicate that high
peak powers can be obtained at these wavelengths even over long
10–100 msec pulses, and as such this wavelength may well be
considered more favorably in the future for hair removal. Clearly
darker skin types would require reduced fluence, efficient cooling
and longer pulse duration, but Asians and Caucasians in particular
could benefit from the significant melanin/hemoglobin absorption
differential with this wavelength [7].
One practical question relates to the application of this device
on the skin. The treatment tip would have to be in contact with the
skin because of the divergent nature of the wave-front. The
proposed hand piece is envisaged as a 1–5 cm (in length)
interchangeable tip with contact cooling. The smallest spot would
be 1 mm. This might be further reduced by a truncating block or
spatial filter located at the proximal end of the distal treatment tip.
Given that a pulsed dye Traser is tunable, is should be able to
mimic devices from below the 532 nm (green) to the near infrared
wavelength simply by changing the dye kit. The durability of the
flashlamps in a Traser are likely to be significant, given the
relatively low peak powers and longer individual pulse durations
(0.45 msec) and the consequent wear and tend on both the lamps.
The same would be true for the dye.
Trasers should compare well with an intense pulse lights (IPL).
Trasers have chromophor-absorption selective spectra that are
quite similar to those of lasers. Since there is less interference by
wavelengths induced by less selective absorption, the fluences
required to induce the same peak power output is reduced. Even
with short pulses, Trasers are capable of producing high peak
powers within a narrow wavelength spectrum, a feature impossible
in the case of IPLs. The fluences delivered from a Traser are in
parity with, or exceed, those delivered by a comparable laser, even
at short pulse-durations. This is even more evident when
compared to an IPL.
Lasers are generally considered by the public to be state-of-the-
art devices for achieving optimal outcomes in a wide array of
matters. However in the medical world, there is a debate about
which is optimal, a laser or an intense pulsed light, for conditions
such as port wine stains, telangiectases, skin pigmentation and hair
removal. In practice both have their places [8].
The Earth is drenched by a wide array of wavelengths of light
and our diverse biological nature is engineered to respond to many
of them. It’s not dependent upon a few single wavelengths of light.
As an example, hemoglobin has a broad range of light absorption,
and yet unless we are using a filtered intense pulsed light, we
generally offer the hemoglobin just one wavelength for a
therapeutic response. One could argue that a pulse dye Traser’s
broader range of wavelengths will have an enhanced range of
penetration depth and internal scattering, both of which could
augment heating of the more superficial and deeper vascular
components.
When the pulsed dye laser was first produced, a wavelength of
577 nm was deliberately engineered because it was considered
optimal for an absorption peak of oxygenated haemoglobin [9].
However, this wavelength was so well absorbed by hemoglobin
that it failed to coagulate the entire diameter of the blood vessel.
Oon Tien Tan et al experimented with wavelengths above and
below the 577 nm peak, and found that moving up to 585 nm
decreased the absorption but doubled the depth of penetration,
two essential measures which enhanced the efficacy of the pulsed
dye laser (PDL) [10]. In an attempt to further augment the heating
of a heterogeneous group of vessels, most PDLs now deliver a train
of 595 nm pulses comprised of up to eight 0.45 msec pulses over a
period of up to 40 msec [11]. A pulsed dye Traser can be
engineered to emulate the PDL with multiple short pulses, or to
deliver single true continues pulses of up to 100 msec.
This paper has concentrated on the science behind the concept
of a Traser. There is no such device currently available or cleared
by the FDA. The significance of a single device with the
TRASER
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35899functionality of many will be intriguing to clinicians and engineers.
It could represent an alternative generation of devices to be used in
clinical medicine.
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